Retour
Fourchette du Jour
14,20 €
14,92 €
Fourchette 52 Semaines
3,50 €
25,77 €
Volume
1 627 964
Moyenne 50J / 200J
19,78 €
/
11,73 €
Clôture Précédente
15,03 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -24,8 | 0,3 |
| P/B | 4,1 | 2,9 |
| ROE % | -16,9 | 3,7 |
| Net Margin % | -31,2 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Objectif de Cours des Analystes
Hold
31,75 €
+115.7%
Low: 22,00 €
High: 37,00 €
BPA Prévisionnel
-1,52 €
CA Est.
57 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-1,60 €
-4,15 € – -0,19 €
|
170 M | 1 |
| FY2029 |
-2,13 €
-5,51 € – -0,25 €
|
120 M | 1 |
| FY2028 |
-2,26 €
-2,90 € – -1,47 €
|
38 M | 5 |
Points Clés
Debt/Equity of 0,17 — conservative balance sheet
Negative free cash flow of -27,50M
PEG of 0,64 suggests growth is underpriced
Capital efficient — spends only 3,80% of revenue on capex
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)63,54%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-16,94%
ROIC-14,93%
Net Margin-31,23%
Op. Margin-43,83%
Sécurité
Debt / Equity
0,17
Current Ratio6,12
Interest Coverage0,00
Valorisation
P/E Ratio
-24,82
P/B Ratio4,11
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 63,54% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 123,67M | Net Income (TTM) | -38,63M |
| ROE | -16,94% | ROA | -8,61% |
| Gross Margin | 93,24% | Operating Margin | -43,83% |
| Net Margin | -31,23% | Free Cash Flow (TTM) | -27,50M |
| ROIC | -14,93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,17 | Current Ratio | 6,12 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -24,82 | P/B Ratio | 4,11 |
| P/S Ratio | 7,75 | PEG Ratio | 0,64 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 958,61M | Enterprise Value | 867,92M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 123,67M | 75,62M | 0,0 | 0,0 | 0,0 |
| Net Income | -38,63M | -72,70M | -135,35M | -108,50M | -73,96M |
| EPS (Diluted) | -0,46 | -0,98 | -2,63 | -2,30 | -1,59 |
| Gross Profit | 115,32M | 67,50M | -6,22M | 0,0 | 0,0 |
| Operating Income | -54,21M | -81,11M | -143,31M | -112,38M | -72,88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 448,66M | 438,73M | 303,76M | 342,39M | 366,33M |
| Total Liabilities | 215,60M | 215,80M | 124,51M | 70,98M | 18,81M |
| Shareholders' Equity | 233,06M | 222,94M | 179,25M | 271,41M | 347,52M |
| Total Debt | 39,19M | 42,72M | 46,04M | 47,00M | 0,0 |
| Cash & Equivalents | 129,88M | 224,25M | 128,10M | 54,91M | 346,07M |
| Current Assets | 393,19M | 377,44M | 236,21M | 275,89M | 348,67M |
| Current Liabilities | 64,21M | 156,95M | 46,59M | 25,57M | 16,64M |